BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Acetaminophen, rs2300478, LEP, T cell differentiation, Arthritis, Neuron)
Bookmark Forward

QuickView for AGT (gene)


Body Atlas

Most Correlated Tissues

  1. Fetal liver
  2. Liver
  3. Spinal cord
  4. Fetal lung
  5. Cerebellum peduncles
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Low blood pressure
  2. Hypertensive disorder
  3. Injury of eye region
  4. Kidney disease
  5. Hyperoxia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. flavanone
  2. temsirolimus
  3. SN-38
  4. Buparlisib
  5. Apitolisib
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ZNF598
  2. RAPGEF3
  3. SOD2
  4. PRNP
  5. PLN
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Low-intensity pulsed ultrasound prevents angiotensin II-induced aortic smooth muscle cell phenotypic…
  2. Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII-induced angiogenesis by inte…
  3. The emerging role of angiotensinogen in cardiovascular diseases.
  4. Hepatic and proximal tubule angiotensinogen play distinct roles in kidney dysfunction, glomerular an…
  5. Angiotensin II infusion in COVID-19: An international, multicenter, registry-based study.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ionis AGT-LRx in Healthy Volunteers
  2. A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx
  3. A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participant…
  4. A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chroni…
  5. A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Adm…
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.